Kiora Pharmaceuticals, Inc.

DB:7EY Stock Report

Market Cap: €12.6m

Kiora Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Brian Strem

Chief executive officer

US$802.3k

Total compensation

CEO salary percentage51.9%
CEO tenure3yrs
CEO ownership1.0%
Management average tenure2.8yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brian Strem's remuneration changed compared to Kiora Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$2m

Dec 31 2023US$802kUS$416k

-US$13m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$714kUS$400k

-US$14m

Sep 30 2022n/an/a

-US$17m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$659kUS$169k

-US$14m

Compensation vs Market: Brian's total compensation ($USD802.27K) is above average for companies of similar size in the German market ($USD525.52K).

Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.


CEO

Brian Strem (44 yo)

3yrs

Tenure

US$802,274

Compensation

Dr. Brian M. Strem, Ph D., is Co-Founder and Director at Okogen, Inc. He served as Principal Financial and Accounting Officer of Kiora Pharmaceuticals, Inc. since June 16, 2022. He serves as President, Dir...


Leadership Team

NamePositionTenureCompensationOwnership
Brian Strem
President3yrsUS$802.27k1.02%
$ 127.7k
Melissa Tosca
Executive Vice President of Finance1.8yrsUS$387.48k0.39%
$ 49.1k
Eric Daniels
Chief Development Officer2.8yrsUS$652.31k0.63%
$ 78.7k
Stefan Sperl
Executive Vice President of CMC & Operationsno datano datano data

2.8yrs

Average Tenure

44yo

Average Age

Experienced Management: 7EY's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Brian Strem
President3yrsUS$802.27k1.02%
$ 127.7k
Lisa Walters-Hoffert
Independent Directorno datano datano data
Daniel Durrie
Member of Scientific Advisory Board7.3yrsno datano data
Praveen Tyle
Independent Chairman of the Board16.1yrsUS$98.25k0.00040%
$ 50.3
Paul Karpecki
Member of Scientific Advisory Board6.8yrsno datano data
Aron Shapiro
Director3.3yrsUS$70.12k0%
$ 0
Victor Perez
Member of Scientific Advisory Board6.4yrsno datano data
David Hollander
Independent Director2.6yrsUS$77.62k0%
$ 0
Erin Parsons
Non-Employee Independent Director2.4yrsUS$84.50k0.18%
$ 22.3k
Allen Ho
Member of Scientific Advisory Boardno datano datano data
Christine Kay
Member of Scientific Advisory Boardno datano datano data
Francis Mah
Member of Scientific Advisory Boardno datano datano data

3.3yrs

Average Tenure

53yo

Average Age

Experienced Board: 7EY's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.